Lv1
40 积分 2026-04-25 加入
The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment
1个月前
已完结
Anti-PD-L1 nanobody guided in situ self-assembly and release of IOX1 and FDU for enhanced cancer chemo-immunotherapy
1个月前
已完结
Anti-tumor activity of an αPD-L1-PE38 immunotoxin delivered by engineered Nissle 1917
1个月前
已完结
Development and Characterization of an Anti-PD-L1 Immunotoxin for Targeted Cancer Therapy
1个月前
已完结
Unlocking the Role of Senescent Cell–Derived Extracellular Vesicles in Immune-Mediated Tumor Suppression
2个月前
已完结
Prognostic role of PD-L1 expression in patients with advanced renal cell carcinoma (RCC) treated with sunitinib
2个月前
已关闭
Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma
2个月前
已完结
皖公网安备34019202002308
